Skip to main content
Cantourage Group SE logo

Cantourage Group SE — Investor Relations & Filings

Ticker · HIGH ISIN · DE000A3DSV01 LEI · 3912003NCTLO6YHA9V48 XMIL Manufacturing
Filings indexed 109 across all filing types
Latest filing 2024-11-07 Earnings Release
Country DE Germany
Listing XMIL HIGH

About Cantourage Group SE

https://www.cantourage.com/

Cantourage Group SE is a company specializing in the production and distribution of medical cannabis. It operates a platform that enables global cultivators to access the European market by managing the import, processing, and distribution of cannabis products. The company processes raw materials from its international partners into EU-compliant finished medicinal products, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Its portfolio features a diverse range of cannabis strains. Additionally, Cantourage operates the 'Telecan' telemedicine platform to facilitate patient access to cannabis-based therapies. The company's strategy involves developing new cannabis medicines and working to lower the cost of treatment for patients.

Recent filings

Filing Released Lang Actions
Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth
Earnings Release Classification · 100% confidence The document is a press release disseminated via EQS-News, titled "Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth." It explicitly mentions "9 Month figures/Quarter Results" and provides detailed financial highlights for Q3 2024 and the first nine months of 2024 (January 1 to September 30, 2024). This content structure—announcing key financial metrics for a recent period (quarterly/interim) immediately following the period end—is characteristic of an Earnings Release (ER). While it contains interim financial data, it is presented as a news announcement rather than the comprehensive, detailed report itself (which would be an IR). Since it focuses on the immediate release of period results, ER is the most appropriate classification. Q3 2024
2024-11-07 English
Halbjahresabschluss 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenabschluss' (Interim Financial Statement) for Cantourage Group SE for the period ending June 30, 2024. It contains detailed balance sheets, profit and loss statements, and explanatory notes (Anhang). This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2024
2024-10-30 German
The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024
Earnings Release Classification · 100% confidence The document is a news release titled "Cantourage Group SE reports record quarter in third quarter of 2024". It explicitly mentions key financial metrics for Q3 2024 (Sales revenue of EUR 13.2 million, EBITDA of EUR 0.9 million to EUR 1.1 million) and provides a full-year revenue forecast. This structure—announcing key financial results for a specific period (Q3) immediately after the period ends—is characteristic of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR), but rather the initial highlights announcement. The presence of the EQS-News header and the nature of the content confirm it is a timely financial results announcement. Q3 2024
2024-10-10 English
Medizinisches Cannabis boomt: Cantourage Group SE verzeichnet Rekordquartal in Q3 2024
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement dated October 9, 2024, reporting on the company's performance for 'Q3 2024' (July 1 to September 30). It explicitly states key financial figures (EUR 13.2 million revenue) and provides an outlook for the full year. This content structure—a brief, immediate release of key financial highlights for a specific reporting period—is characteristic of an Earnings Release (ER). Although it mentions the results, it is not the comprehensive report itself (like an IR or 10-K). The document is short and serves as the initial public disclosure of the period's financial success. Q3 2024
2024-10-09 German
Cantourage Group SE verzeichnet im Zeitraum Januar bis August 2024 hohere Umsatzerlose als im Gesamtjahr 2023
Earnings Release Classification · 100% confidence The document is a news release from Cantourage Group SE, dated September 4, 2024, detailing significant revenue achievements for the period January to August 2024, including surpassing the total revenue of the entire 2023 fiscal year. It provides key financial highlights (revenue figures, growth rates, and a full-year forecast) and includes commentary from the CEO. This format, focusing on recent performance highlights rather than comprehensive annual or quarterly statements, aligns perfectly with an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), nor is it merely an announcement of a report (RPA). 9M 2024
2024-09-04 German
Cantourage Group SE verzeichnet im Zeitraum Januar bis August 2024 hohere Umsatzerlose als im Gesamtjahr 2023
Earnings Release Classification · 100% confidence The document is a short announcement dated September 3, 2024, labeled as 'Ad-hoc' and 'Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014'. It reports preliminary revenue figures for the period January to August 2024, comparing them to the previous year and the full year 2023, and provides an updated revenue forecast for the full year 2024. This content structure—a brief, immediate release of key financial performance indicators outside of a full quarterly or annual report—is characteristic of an Earnings Release (ER). It is not a full report (10-K or IR), nor is it a transcript (CT) or a general regulatory filing (RNS) when a more specific category like ER fits perfectly. 9M 2024
2024-09-03 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.